Role of Chlamydia in Multiple Sclerosis

Chlamydia and antibodies to them were detected by serological, molecular biological, and culture methods in the sera and cerebrospinal fluid of patients with multiple sclerosis and in the reference groups of subjects without neurological diseases. Correlations between the agent presence in the biological fluids of patients and clinical characteristics of the disease were analyzed. C. pneumoniae were more incident in the biological liquids of patients with multiple sclerosis than in healthy volunteers. On the other hand, the incidence of the agent in the patients was not high and its presence did not correlate with the clinical manifestations. C. trachomatis was equally rare in the patients and volunteers. The studies indicated the existence of a group of patients infected by C. pneumoniae in the cohort of patients with multiple sclerosis, but the impact of this agent for the disease course remains unclear.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    A. V. Morgun, N. V. Kuvacheva, Yu. K. Komleva, et al., Ann. Klin. Eksp. Nevrol., 6, No. 2, 42-51 (2012).

    Google Scholar 

  2. 2.

    E. Boelen, H. W. Steinbusch, A. J. van der Ven, et al., Neurobiol. Aging, 28, No. 4, 524-532 (2006).

    Article  PubMed  Google Scholar 

  3. 3.

    J. Boman, P. M. Roblin, P. Sundstrom, et al., Neurology, 54, No. 1, 265 (2000).

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    C. Breithaupt, A. Schubart, H. Zander, et al., Proc. Natl Acad. Sci. USA, 100, No. 16, 9446-9451 (2003).

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  5. 5.

    T. Derfuss, R. Gurkov, F. Then Bergh, et al., Brain, 124, Pt 7, 1325-1335 (2001).

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    C. Du, S. Y. Yao, A. Ljunggren-Rose, and S. Sriram, J. Exp. Med., 196, No. 12, 1639-1644 (2002).

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  7. 7.

    S. J. Furrows, J. C. Hartley, J. Bell, et al., J. Neurol. Neurosurg. Psychiatry, 75, No. 1, 152-154 (2004).

    PubMed Central  CAS  PubMed  Google Scholar 

  8. 8.

    Q. Hao, N. Miyashita, M. Matsui, et al., Mult. Scler., 8, No. 5, 436-440 (2002).

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    L. J. Heung, C. Luberto, and M. Del Poeta, Infect. Immun., 74, No. 1, 28-39 (2006).

    PubMed Central  CAS  Article  PubMed  Google Scholar 

  10. 10.

    D. Krametter, G. Niederwieser, A. Berghold, et al., Mult. Scler., 7, No. 1, 13-18 (2001).

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    J. Paratt, R. Tavendale, J. O’Riordan, et al., Ibid., 14, No. 3, 292-299 (2008).

    Google Scholar 

  12. 12.

    C. H. Polman, S. C. Reingold, B. Banwell, et al., Ann. Neurol., 69, No. 2, 292-302 (2011).

    PubMed Central  Article  PubMed  Google Scholar 

  13. 13.

    S. Sriram, W. Mitchell, and C. Stratton, Neurology, 50, No. 2, 571-572 (1998).

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    T. Vainas, R. De Graaf, F. R. Stassen, et al., APMIS, 111, No. 2, 363-369 (2003).

    Article  PubMed  Google Scholar 

  15. 15.

    F. C. Westall, J. Clin. Microbiol., 44, No. 6, 2099-2104 (2006).

    PubMed Central  CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to M. V. Ivanova.

Additional information

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 159, No. 5, pp. 605-608, May, 2015

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ivanova, M.V., Kolkova, N.I., Morgunova, E.Y. et al. Role of Chlamydia in Multiple Sclerosis. Bull Exp Biol Med 159, 646–648 (2015). https://doi.org/10.1007/s10517-015-3037-z

Download citation

Key Words

  • multiple sclerosis
  • Chlamydia